| abstract |
COMBINATION OF SOMATOSTATIN ANALOGUE WITH DIFFERENT SELECTIVITY FOR HUMAN SOMATOSTATIN RECEPTOR SUBTIPOSES. The present invention relates to a combination of two or more somatostatin peptidomimetics (SRIFs) (also called somatostatin analogs or SRIFs) that have different selectivity for the five human somatostatin receptor subtypes, the use of such a combination in the treatment. of a disease mediated by somatostatin receptor activation, and to pharmaceutical compositions comprising such a combination. |